Replies to post #12511 on Inovio Pharmaceuticals Inc (INO)

[rawman]

Do the real DD or at least read the last couple hundred posts on this Board. Any response, including a promo or bash from here, might be "interesting," but probably of questionable value!

[ppnlf]

Try this SA article from earlier this year which provides a good factual summary.

http://tinyurl.com/kfk9k6g

The main events since then have been
1. R/S of the shares 1:4
2. Hostile articles by AF at TheStreet considered by many to be efforts at price manipulation (& if so were successful)
3. Significant insider share purchases by Dr Kim and other execs: no sales
4. Strong results from Phase II for Invovio's VGX-3100 cervical dysplasia treatment coupled with SynCon electroporation.

As with all smallish bio companies it is all a case of how you see it.
INO has substantial cash balances & no debt. It has a pipeline of vaccines under development & test. It has a patented delivery programme in SynCon. It has good endorsement from its partnership with Roche.
Longs see it as a steady path to a multi billion $ company under strong management.
The inevitable doubters see it as a hyped retail share.
And traders & flippers see the frequent price volatility as a way to make money.
In the meantime under Dr Kim the business works forward & institutional holdings slowly increase. IMO these will lead to good news for longs. Let's see if the change to the listing to NASDAQ helps the PPS.

But as cracity says you really need to do your own DD.